"tyrosine kinase receptor" trang 7 - tải miễn phí từ tailieuXANH
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
16    47    0
EGFR modulates complement activation in head and neck squamous cell carcinoma

EGFR modulates complement activation in head and neck squamous cell carcinoma
12    49    0
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiationinduced abdominal wall angiosarcoma with low-dose apatinib: A case report

Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiationinduced abdominal wall angiosarcoma with low-dose apatinib: A case report
6    55    0
Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: Implications for treatment and discovery of potential therapeutic signatures

Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: Implications for treatment and discovery of potential therapeutic signatures
12    58    0
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report
4    166    1
Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia

Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia
13    69    0
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
9    85    1
Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report
6    64    0
Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis

Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
8    50    0
Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: An update network meta-analysis

Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: An update network meta-analysis
14    70    0
Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST)

Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST)
8    40    0
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: A multicenter observational study

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: A multicenter observational study
11    55    0
Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia
10    58    0
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls
8    54    0
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
6    59    0
Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs

Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs
9    47    1
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: A retrospective study
10    53    0
Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study

Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study
11    55    0
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis

Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
4    65    0
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: A retrospective cohort study

Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: A retrospective cohort study
9    67    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.